Position in SCLX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15
-$24 QoQ
Shares Held
2
-80.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 72 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $318,890,544 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
362,958 | $92,180,442 | |
| 2 | LLY |
ELI LILLY & Co
|
68,037 | $81,605,624 | |
| 3 | ABBV |
AbbVie Inc.
|
222,751 | $56,053,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
208,546 | $26,798,161 | |
| 5 | AMGN |
Amgen Inc
|
53,858 | $19,503,058 | |
| 6 | NVS |
Novartis AG
|
92,390 | $14,479,360 | |
| 7 | PFE |
Pfizer Inc
|
360,280 | $8,675,542 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
129,525 | $7,463,230 |
All Filings in SCLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15 | 2 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $39 | 6 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $73 | 6 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $118 | 6 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $76 | 13 | Shares | Sole | 2025-08-07 | |
| 2023-06-30 | $389 | 70 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $574 | 70 | Shares | Sole | 2023-04-18 | |
| No filing history on record for this holder in this stock. | ||||||